Joop van Oene

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial

Hans‐Christoph Diener, R. Agosti, Gianni Allais et al. · The Lancet Neurology · 2007 · 161 citations

Cluster Headache, Placebo-controlled Trial, Neurology +2

Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy

Jože Grošelj, Renzo Guerrini, Joop van Oene et al. · Acta Neurologica Scandinavica · 2005 · 51 citations

Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting

Renzo Guerrini, Johannes A. Carpay, Jože Grošelj et al. · Seizure · 2005 · 39 citations · Full text

Broad-spectrum Antiepileptic Drug, Psychotropic Medication, Topiramate Monotherapy +6

Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate

Michael Rösler, Ylva Ginsberg, T. Arngrim et al. · The World Journal of Biological Psychiatry · 2011 · 27 citations

Quality Of Life, Life Assessment, Disability +18

Perimenstrual migraines and their response to preventive therapy with topiramate

Gianni Allais, Margarita Sánchez del Río, Hans‐Christoph Diener et al. · Cephalalgia · 2010 · 26 citations